Gewinn- und Verlustrechnung von Cigna Corporation

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

By connecting information about each person's health, care and coverage, Health Sense℠ helps people receive continuous personalized support, make informed decisions and act sooner Projected to reduce inefficient health care spending by 10% by 2030, improving affordability for employers and customers alike. Watch a demonstration of the new Health Sense customer experience.

Cigna is rated a 'Strong Buy' for its compelling value, robust earnings growth, and capital returns at a forward P/E of 8.9x. CI posted strong Q2 2026 results, raised full-year EPS guidance, and targets 10–14% annual EPS growth through 2030, driven by AI and specialty pharmacy. CI's asset-light model, expanding specialty pharma presence, and aggressive share buybacks support high-teens total return potential annually.

The Cigna Group (CI) Analyst/Investor Day Transcript

Cigna Group NYSE: CI reaffirmed its 2026 outlook and outlined a long-term strategy centered on complex care, technology-enabled personalization and disciplined capital deployment at its 2026 Investor Day.

The Cigna Group (CI) shares are experiencing a significant decline following the company's reaffirmation of its FY26 guidance during its Investor Day. Investors

Cigna said on Wednesday it will invest $3 billion as part ​of a multi-year program to ‌focus on modernizing processes and streamlining workflows, among others, with AI-enabled insights ​and tools to drive growth.

Following deliberate portfolio shaping over the last several years, The Cigna Group is strategically positioned where health care costs are concentrating with multiple avenues for growth Announces "Lead to One" vision, unifying all colleagues around delivering personalization at scale to improve affordability and the patient experience Distinct, industry-leading capabilities in complex care, powered by clinical expertise, data, technology and AI Announces $3B multi-year modernization and productivity initiative to fuel performance Reaffirms 2026 full-year financial guidance and provides long-term financial growth target of 10-14% adjusted EPS CAGR through 2030 BLOOMFIELD, Conn., Sept. 30, 2026 /PRNewswire/ -- Today, at its Investor Day, The Cigna Group (NYSE: CI) will outline its strategy to improve affordability and personalization across the health care continuum.

Cigna Group (NYSE: CI - Get Free Report) has received a consensus rating of "Moderate Buy" from the twenty-three ratings firms that are currently covering the company, Marketbeat.com reports. Eight investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 1 year price target

Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.